This is the list of the largest public listed companies in the Drug Manufacturers—Specialty & Generic industry from Sweden by market capitalization with links to their reference stock.
Company Profile:
Swedish Orphan Biovitrum AB
Market Cap (USD):
$8.73 B
Country:
Sweden
Sector:
Swedish Healthcare
Industry:
Swedish Drug Manufacturers—Specialty & Generic
Company Profile:
Karo Pharma AB
Market Cap (USD):
$1.49 B
(Nov. 1, 2022)
Country:
Sweden
Sector:
Swedish Healthcare
Industry:
Swedish Drug Manufacturers—Specialty & Generic
Company Profile:
BioGaia AB
Market Cap (USD):
$1.18 B
Country:
Sweden
Sector:
Swedish Healthcare
Industry:
Swedish Drug Manufacturers—Specialty & Generic
Company Profile:
Calliditas Therapeutics AB (publ)
Market Cap (USD):
$1.05 B
Country:
Sweden
Sector:
Swedish Healthcare
Industry:
Swedish Drug Manufacturers—Specialty & Generic
Company Profile:
Swedencare AB
Market Cap (USD):
$859.6 M
Country:
Sweden
Sector:
Swedish Healthcare
Industry:
Swedish Drug Manufacturers—Specialty & Generic
Company Profile:
Probi AB
Market Cap (USD):
$311.3 M
Country:
Sweden
Sector:
Swedish Healthcare
Industry:
Swedish Drug Manufacturers—Specialty & Generic
Company Profile:
EQL Pharma AB
Market Cap (USD):
$156.7 M
Country:
Sweden
Sector:
Swedish Healthcare
Industry:
Swedish Drug Manufacturers—Specialty & Generic
Company Profile:
Oasmia Pharmaceutical AB
Market Cap (USD):
$76.7 M
(June 1, 2022)
Country:
Sweden
Sector:
Swedish Healthcare
Industry:
Swedish Drug Manufacturers—Specialty & Generic
Company Profile:
Orexo AB
Market Cap (USD):
$66.0 M
Country:
Sweden
Sector:
Swedish Healthcare
Industry:
Swedish Drug Manufacturers—Specialty & Generic
Company Profile:
Enzymatica AB
Market Cap (USD):
$40.5 M
Country:
Sweden
Sector:
Swedish Healthcare
Industry:
Swedish Drug Manufacturers—Specialty & Generic
Company Profile:
Emplicure AB
Country:
Sweden
Sector:
Swedish Healthcare
Industry:
Swedish Drug Manufacturers—Specialty & Generic